Response to "Can CYP3A activity be evaluated for drug interaction using a nanogram dose of probe drug?": Evaluation of CYP3A activity with microdoses of midazolam
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) Editorial |
| Sprache: | Englisch |
| Veröffentlicht: |
6 February 2014
|
| In: |
Clinical pharmacology & therapeutics
Year: 2014, Jahrgang: 95, Heft: 5, Pages: 490-491 |
| ISSN: | 1532-6535 |
| DOI: | 10.1038/clpt.2014.28 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1038/clpt.2014.28
|
| Verfasserangaben: | N Hohmann, B Halama, N Siller, G Mikus, WE Haefeli |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1545758034 | ||
| 003 | DE-627 | ||
| 005 | 20220813030741.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 160805s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/clpt.2014.28 |2 doi | |
| 035 | |a (DE-627)1545758034 | ||
| 035 | |a (DE-576)47575803X | ||
| 035 | |a (DE-599)BSZ47575803X | ||
| 035 | |a (OCoLC)1340927234 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Hohmann, Nicolas |d 1983- |e VerfasserIn |0 (DE-588)1018788999 |0 (DE-627)683426052 |0 (DE-576)356371816 |4 aut | |
| 245 | 1 | 0 | |a Response to "Can CYP3A activity be evaluated for drug interaction using a nanogram dose of probe drug?" |b Evaluation of CYP3A activity with microdoses of midazolam |c N Hohmann, B Halama, N Siller, G Mikus, WE Haefeli |
| 264 | 1 | |c 6 February 2014 | |
| 300 | |a 2 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 05.08.2016 | ||
| 700 | 1 | |a Halama, Birte |d 1986- |e VerfasserIn |0 (DE-588)1034229117 |0 (DE-627)745127509 |0 (DE-576)381858553 |4 aut | |
| 700 | 1 | |a Siller, Nelly |e VerfasserIn |0 (DE-588)1055021361 |0 (DE-627)792516095 |0 (DE-576)411094289 |4 aut | |
| 700 | 1 | |a Mikus, Gerd |e VerfasserIn |0 (DE-588)110903137 |0 (DE-627)691097941 |0 (DE-576)336988710 |4 aut | |
| 700 | 1 | |a Haefeli, Walter E. |d 1958- |e VerfasserIn |0 (DE-588)124572359 |0 (DE-627)656806141 |0 (DE-576)340514221 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical pharmacology & therapeutics |d Hoboken, NJ : Wiley-Blackwell, 1960 |g 95(2014), 5, Seite 490-491 |h Online-Ressource |w (DE-627)325793247 |w (DE-600)2040184-X |w (DE-576)094531668 |x 1532-6535 |7 nnas |a Response to "Can CYP3A activity be evaluated for drug interaction using a nanogram dose of probe drug?" Evaluation of CYP3A activity with microdoses of midazolam |
| 773 | 1 | 8 | |g volume:95 |g year:2014 |g number:5 |g pages:490-491 |g extent:2 |a Response to "Can CYP3A activity be evaluated for drug interaction using a nanogram dose of probe drug?" Evaluation of CYP3A activity with microdoses of midazolam |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/clpt.2014.28 |x Verlag |x Resolving-System |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20160805 | ||
| 993 | |a Editorial | ||
| 994 | |a 2014 | ||
| 998 | |g 124572359 |a Haefeli, Walter E. |m 124572359:Haefeli, Walter E. |d 910000 |d 910100 |e 910000PH124572359 |e 910100PH124572359 |k 0/910000/ |k 1/910000/910100/ |p 5 |y j | ||
| 998 | |g 110903137 |a Mikus, Gerd |m 110903137:Mikus, Gerd |d 910000 |d 910100 |e 910000PM110903137 |e 910100PM110903137 |k 0/910000/ |k 1/910000/910100/ |p 4 | ||
| 998 | |g 1055021361 |a Siller, Nelly |m 1055021361:Siller, Nelly |d 910000 |d 910100 |e 910000PS1055021361 |e 910100PS1055021361 |k 0/910000/ |k 1/910000/910100/ |p 3 | ||
| 998 | |g 1034229117 |a Halama, Birte |m 1034229117:Halama, Birte |d 910000 |d 910100 |e 910000PH1034229117 |e 910100PH1034229117 |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 998 | |g 1018788999 |a Hohmann, Nicolas |m 1018788999:Hohmann, Nicolas |d 910000 |d 910100 |e 910000PH1018788999 |e 910100PH1018788999 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1545758034 |e 2936091640 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"display":"Hohmann, Nicolas","role":"aut","roleDisplay":"VerfasserIn","given":"Nicolas","family":"Hohmann"},{"given":"Birte","roleDisplay":"VerfasserIn","role":"aut","display":"Halama, Birte","family":"Halama"},{"family":"Siller","role":"aut","roleDisplay":"VerfasserIn","given":"Nelly","display":"Siller, Nelly"},{"family":"Mikus","display":"Mikus, Gerd","role":"aut","roleDisplay":"VerfasserIn","given":"Gerd"},{"roleDisplay":"VerfasserIn","role":"aut","given":"Walter E.","display":"Haefeli, Walter E.","family":"Haefeli"}],"language":["eng"],"physDesc":[{"extent":"2 S."}],"name":{"displayForm":["N Hohmann, B Halama, N Siller, G Mikus, WE Haefeli"]},"id":{"eki":["1545758034"],"doi":["10.1038/clpt.2014.28"]},"origin":[{"dateIssuedKey":"2014","dateIssuedDisp":"6 February 2014"}],"relHost":[{"disp":"Response to \"Can CYP3A activity be evaluated for drug interaction using a nanogram dose of probe drug?\" Evaluation of CYP3A activity with microdoses of midazolamClinical pharmacology & therapeutics","language":["eng"],"origin":[{"publisherPlace":"Hoboken, NJ ; St. Louis, Mo. ; Basingstoke","dateIssuedKey":"1960","dateIssuedDisp":"1960-","publisher":"Wiley-Blackwell ; Mosby ; Nature Publ. Group"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Clinical pharmacology & therapeutics","title_sort":"Clinical pharmacology & therapeutics","subtitle":"CPT ; official publication of the American Society for Clinical Pharmacology and Therapeutics and the American Society for Pharmacology and Experimental Therapeutics"}],"corporate":[{"display":"American Society for Clinical Pharmacology and Therapeutics","roleDisplay":"Herausgebendes Organ","role":"isb"},{"role":"isb","roleDisplay":"Herausgebendes Organ","display":"American Society for Pharmacology and Experimental Therapeutics"}],"id":{"doi":["10.1002/(ISSN)1532-6535"],"issn":["1532-6535"],"eki":["325793247"],"zdb":["2040184-X"]},"titleAlt":[{"title":"CPT"},{"title":"Clinical pharmacology and therapeutics"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.1960 -"],"note":["Gesehen am 18.02.2016"],"part":{"volume":"95","issue":"5","text":"95(2014), 5, Seite 490-491","pages":"490-491","year":"2014","extent":"2"},"recId":"325793247"}],"title":[{"title":"Response to \"Can CYP3A activity be evaluated for drug interaction using a nanogram dose of probe drug?\"","title_sort":"Response to \"Can CYP3A activity be evaluated for drug interaction using a nanogram dose of probe drug?\"","subtitle":"Evaluation of CYP3A activity with microdoses of midazolam"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 05.08.2016"],"recId":"1545758034"} | ||
| SRT | |a HOHMANNNICRESPONSETO6201 | ||